128 related articles for article (PubMed ID: 7712756)
1. Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial.
Voerman BJ; Strack van Schijndel RJ; Groeneveld AB; de Boer H; Nauta JP; Thijs LG
Crit Care Med; 1995 Apr; 23(4):665-73. PubMed ID: 7712756
[TBL] [Abstract][Full Text] [Related]
2. Effects of human growth hormone on fuel utilization and mineral balance in critically ill patients on full intravenous nutritional support.
Voerman BJ; Strack van Schijndel RJ; de Boer H; Groeneveld AB; Nauta JP; van der Veen EA; Thijs LG
J Crit Care; 1994 Sep; 9(3):143-50. PubMed ID: 7981777
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant human growth hormone in patients with severe sepsis.
Voerman HJ; van Schijndel RJ; Groeneveld AB; de Boer H; Nauta JP; van der Veen EA; Thijs LG
Ann Surg; 1992 Dec; 216(6):648-55. PubMed ID: 1466618
[TBL] [Abstract][Full Text] [Related]
4. Time course and variability of the endocrine and metabolic response to severe sepsis.
Voerman HJ; Groeneveld AB; de Boer H; Strack van Schijndel RJ; Nauta JP; van der Veen EA; Thijs LG
Surgery; 1993 Nov; 114(5):951-9. PubMed ID: 8236020
[TBL] [Abstract][Full Text] [Related]
5. Frequent intravenous pulses of growth hormone together with glutamine supplementation in prolonged critical illness after multiple trauma: effects on nitrogen balance, insulin resistance, and substrate oxidation.
Duska F; Fric M; Waldauf P; Pazout J; Andel M; Mokrejs P; Tůma P; Pachl J
Crit Care Med; 2008 Jun; 36(6):1707-13. PubMed ID: 18496372
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone/insulin-like growth factors axis in children undergoing cardiac surgery.
Balcells J; Moreno A; Audí L; Roqueta J; Iglesias J; Carrascosa A
Crit Care Med; 2001 Jun; 29(6):1234-8. PubMed ID: 11395611
[TBL] [Abstract][Full Text] [Related]
7. Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries.
Roth E; Valentini L; Semsroth M; Hölzenbein T; Winkler S; Blum WF; Ranke MB; Schemper M; Hammerle A; Karner J
J Trauma; 1995 Jan; 38(1):136-41. PubMed ID: 7538170
[TBL] [Abstract][Full Text] [Related]
8. Administration of human recombinant insulin-like growth factor-I in critically ill patients.
Yarwood GD; Ross RJ; Medbak S; Coakley J; Hinds CJ
Crit Care Med; 1997 Aug; 25(8):1352-61. PubMed ID: 9267949
[TBL] [Abstract][Full Text] [Related]
9. Effect of intensive insulin therapy on the somatotropic axis of critically ill children.
Gielen M; Mesotten D; Brugts M; Coopmans W; Van Herck E; Vanhorebeek I; Baxter R; Lamberts S; Janssen JA; Van den Berghe G
J Clin Endocrinol Metab; 2011 Aug; 96(8):2558-66. PubMed ID: 21632816
[TBL] [Abstract][Full Text] [Related]
10. Magnesium repletion and its effect on potassium homeostasis in critically ill adults: results of a double-blind, randomized, controlled trial.
Hamill-Ruth RJ; McGory R
Crit Care Med; 1996 Jan; 24(1):38-45. PubMed ID: 8565536
[TBL] [Abstract][Full Text] [Related]
11. Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia.
Deane AM; Chapman MJ; Fraser RJ; Summers MJ; Zaknic AV; Storey JP; Jones KL; Rayner CK; Horowitz M
Crit Care Med; 2010 May; 38(5):1261-9. PubMed ID: 20228679
[TBL] [Abstract][Full Text] [Related]
12. Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective, randomized, controlled study.
Pichard C; Kyle U; Chevrolet JC; Jolliet P; Slosman D; Mensi N; Temler E; Ricou B
Crit Care Med; 1996 Mar; 24(3):403-13. PubMed ID: 8625627
[TBL] [Abstract][Full Text] [Related]
13. Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury.
Hatton J; Kryscio R; Ryan M; Ott L; Young B
J Neurosurg; 2006 Dec; 105(6):843-52. PubMed ID: 17405254
[TBL] [Abstract][Full Text] [Related]
14. Systemic and splanchnic metabolic response to exogenous human growth hormone.
Dahn MS; Lange MP
Surgery; 1998 May; 123(5):528-38. PubMed ID: 9591005
[TBL] [Abstract][Full Text] [Related]
15. Failure of anabolism in malnourished cancer patients receiving growth hormone: a clinical research center study.
Tayek JA; Brasel JA
J Clin Endocrinol Metab; 1995 Jul; 80(7):2082-7. PubMed ID: 7608259
[TBL] [Abstract][Full Text] [Related]
16. Protein turnover, lipolysis, and endogenous hormonal secretion in critically ill children.
Cogo PE; Carnielli VP; Rosso F; Cesarone A; Giordano G; Faggian D; Plebani M; Barreca A; Zacchello F
Crit Care Med; 2002 Jan; 30(1):65-70. PubMed ID: 11902289
[TBL] [Abstract][Full Text] [Related]
17. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease.
Timmins AC; Cotterill AM; Hughes SC; Holly JM; Ross RJ; Blum W; Hinds CJ
Crit Care Med; 1996 Sep; 24(9):1460-6. PubMed ID: 8797616
[TBL] [Abstract][Full Text] [Related]
18. Substrate interaction in intravenous feeding: comparative effects of carbohydrate and fat on amino acid utilization in fasting man.
Wolfe BM; Culebras JM; Sim AJ; Ball MR; Moore FD
Ann Surg; 1977 Oct; 186(4):518-40. PubMed ID: 410376
[TBL] [Abstract][Full Text] [Related]
19. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
Murphy MG; Plunkett LM; Gertz BJ; He W; Wittreich J; Polvino WM; Clemmons DR
J Clin Endocrinol Metab; 1998 Feb; 83(2):320-5. PubMed ID: 9467534
[TBL] [Abstract][Full Text] [Related]
20. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
